Send Inquiry

Request To Call Back

Dexmedetomidine Hydrochloride Injection

Get a Price/Quote

MOQ : 100 Boxes

Dexmedetomidine Hydrochloride Injection Specification

Molecular Formula
C13H16N2 HCl

CAS No
145108-58-3

Grade
Pharmaceutical Grade

Purity
>99%

Application
Pain relieve

Formulations Type
Injectables

Formulations Form
Liquid

Treatments & Functions
Used as a sedative, anxiolytic, and adjunct to anesthesia.

Gender/Age Group
Suitable For All Ages

Dosage Guidelines
As directed by physician. Generally, loading dose of 1 mcg/kg over 10 minutes followed by maintenance.

Volume
2 ml, 1 ml, and 4 ml ampoules

Storage Instructions
Store in Cool

Route of Administration
Intravenous (IV) infusion

Brand Name
Dexmedetomidine Hydrochloride Injection

Regulatory Approvals
WHO-GMP, ISO certified facilities

Strength
100 mcg/ml

Shelf Life
24 months

Packaging Type
Glass ampoule

Prescription/Non Prescription
Prescription Only

Usage
Hospital, clinical, anesthesia support

Color
Clear, colorless to slightly yellow solution

Dexmedetomidine Hydrochloride Injection Trade Information

Minimum Order Quantity
100 Boxes

FOB Port
Mundra Port

Supply Ability
100000 Boxes Per Month

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Domestic Market
All India

Certifications
ISO, GMP, WHO

About Dexmedetomidine Hydrochloride Injection

Precedex Injection

Product Specifications

Drug Type	Generic Drugs
Physical Form	Liquid
Dosage Guidelines	Consult your Doctor
Suitable For	Suitable For All

Product Description

In the entire pharmaceutical industry, our company is a well-known exporter of a wide stock of Precedex Inj (Dexmedetomidine Hydrochloride Injection). The injection is indicated for the sedation of non-intubated patients before and during surgical and other procedures. With the help of our expert pharmacists, we make sure to source this Precedex Inj (Dexmedetomidine Hydrochloride Injection) from reputed vendors in the market.
PrecedexTM is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Precedex should be administered by continuous infusion not to exceed 24 hours.
Precedex has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue Precedex prior to extubation.

Key points:

This is a sterile and nonpyrogenic solution suitable for intravenous infusion

Preparation of Solution:

Strict aseptic technique must always be maintained during handling of Precedex.Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Specifications:

Brand : Precedex Inj
Contain : Dexmedetomidine Hydrochloride inj
Strength : 80mcg/20ml ,100mcg/2 ml, 100mcg/1 ml
Packing : Vail

Dosage Adjustment:

Due to possible pharmacodynamic interactions, a reduction in dosage of Precedex or other concomitant anesthetics, sedatives, hypnotics or may be required when co-administered.Dosage reductions may need to be considered for adult patients with hepatic impairment, and geriatric patients.

Precise Sedation for Clinical Needs

Dexmedetomidine Hydrochloride Injection offers reliable sedation, analgesia, and anxiolysis when administered intravenously. It is indicated as an adjunct to anesthesia and pain management, supporting controlled and tailored care during procedures in hospitals and clinics. The products quality is upheld by pharmaceutical-grade standards and rigorous regulatory approvals.

Flexible Dosing and Safe Handling

Physicians typically initiate Dexmedetomidine Hydrochloride Injection with a loading dose of 1 mcg/kg over 10 minutes, followed by maintenance dosing as clinically needed. For optimal results and safety, dosing should always be determined by medical practitioners, considering the patients age and condition. The ampoules are designed for easy handling and precise IV administration.

Regulatory Assurance and Storage Guidelines

Manufactured in WHO-GMP and ISO-certified facilities, this injectable formulation meets stringent global standards. It is shipped in glass ampoules and retains its potency for up to 24 months when stored in a cool place. Healthcare providers are assured of consistent quality and efficacy throughout the shelf life.

FAQs of Dexmedetomidine Hydrochloride Injection:

Q: How is Dexmedetomidine Hydrochloride Injection administered in clinical settings?

A: Dexmedetomidine Hydrochloride Injection is administered as an intravenous (IV) infusion, beginning with a recommended loading dose of 1 mcg/kg over 10 minutes, followed by a maintenance dose as directed by the physician.

Q: What conditions does Dexmedetomidine Hydrochloride Injection treat or support?

A: This medication is primarily used as a sedative, anxiolytic, and adjunct to anesthesia in hospital and clinical environments. It is also used for pain relief and procedural support under medical supervision.

Q: When should Dexmedetomidine Hydrochloride Injection be used during patient care?

A: Dexmedetomidine is indicated during procedures requiring sedation, pain control, or anxiety reduction, such as surgeries or intensive care interventions, following physician evaluation and prescription.

Q: Where should Dexmedetomidine Hydrochloride Injection be stored to maintain efficacy?

A: The ampoules should be stored in a cool environment to preserve their potency and safety throughout their 24-month shelf life. Strict adherence to storage guidelines is essential.

Q: What are the dosage guidelines for Dexmedetomidine Hydrochloride Injection?

A: Dosage is determined by the treating physician, based on patient condition and clinical response. Generally, the initial loading dose is 1 mcg/kg over 10 minutes, followed by maintenance as needed.

Q: How does Dexmedetomidine Hydrochloride Injection benefit patients during anesthesia?

A: The injection helps achieve controlled sedation and pain management, reducing the need for additional anesthetics and supporting smoother procedural outcomes with reduced patient anxiety.

Tell us about your requirement